Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04609917
Recruitment Status : Completed
First Posted : October 30, 2020
Last Update Posted : October 30, 2020
Sponsor:
Information provided by (Responsible Party):
Yanglin Pan, Air Force Military Medical University, China

Brief Summary:

Endoscopic Retrograde Cholangiopancreatography (ERCP) is one of the most technically challenging procedures in gastrointestinal endoscopy. Selective deep cannulation is a critical step for the performance of ERCP. The incidence of difficult cannulation has been reported in many studies, ranging from 10% to 40% in patients with native papilla. Difficult cannulation is an independent risk factor for post-ERCP pancreatitis (PEP).

The definition of difficult cannulation has been proposed by European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Initial cannulation is considered difficult with the presence of one or more of the following: more than 5 min for attempting to cannulate; more than 5 contacts with the papilla; more than 1 unintended pancreatic duct cannulation or opacification. The clear definition of difficult cannulation is important for making decisions during or after ERCP, including determining the appropriate time to transfer to advanced cannulation techniques (e.g. early precut) and whether prophylactic methods should be administrated to reduce the risk of PEP. Although 5-5-1 criteria have been widely used during ERCP practice or in relevant studies, it remains unclear whether the current criteria are suitable for the cannulation procedure with trainee involvement. Because of inexperienced manipulation of the scope and accessories, the involvement of trainees generally increases the overall cannulation time and attempts, which are the two important parameters in the criteria of difficult cannulation. Thus, the investigators hypothesized that the definition of difficult cannulation in trainee-involved cannulation might be different from the traditional 5-5-1 criteria.


Condition or disease Intervention/treatment
Biliary Cannulation Endoscopic Retrograde Cholangiopancreatography Procedure: trainee invlovement

Layout table for study information
Study Type : Observational
Actual Enrollment : 4415 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Proposal of Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation Procedure
Actual Study Start Date : March 1, 2020
Actual Primary Completion Date : October 1, 2020
Actual Study Completion Date : October 20, 2020

Group/Cohort Intervention/treatment
trainee group
Patients with native papilla who underwent selective biliary cannulation with trainee involvement
Procedure: trainee invlovement
Patients underwent selective biliary cannulation with trainee involvement

non-trainee group
Patients with native papilla who underwent selective biliary cannulation without trainee involvement



Primary Outcome Measures :
  1. rates of difficult cannulation [ Time Frame: 2 hours ]
    The proportion of the participants with cannulation-related parameters (cannulation time, cannulation attempts, or inadvertent PD cannulation) above the 75% percentile


Secondary Outcome Measures :
  1. incidences of PEP [ Time Frame: 48 hours ]
  2. overall adverse events [ Time Frame: 48 hours ]
  3. the proportion of advanced cannulation methods [ Time Frame: 4 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with native papilla who underwent ERCP in Xijing Hospital in China
Criteria

Inclusion Criteria:

  • patients with native papilla

Exclusion Criteria:

  • indications of major or minor pancreatic duct (PD) cannulation; no attempts of cannulation due to inaccessible papilla; cannulation via the papillary fistula; patients with duodenal stenosis or anatomical deformity secondary to prior surgery.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04609917


Locations
Layout table for location information
China, Shaanxi
Endoscopic center, Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, China, 710032
Sponsors and Collaborators
Air Force Military Medical University, China
Publications:
Layout table for additonal information
Responsible Party: Yanglin Pan, Associate Professor, Air Force Military Medical University, China
ClinicalTrials.gov Identifier: NCT04609917    
Other Study ID Numbers: KY20201021-2
First Posted: October 30, 2020    Key Record Dates
Last Update Posted: October 30, 2020
Last Verified: October 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Yanglin Pan, Air Force Military Medical University, China:
ERCP
Difficult cannulation
Trainee
PEP